Skip to content

UroGen Pharma Ltd

US · URGN #2773 by market cap Listed 2017
27.65 -4.08 -12.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About UroGen Pharma Ltd

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Founded
2004
CEO
Ms. Elizabeth Barrett
Employees
291
Headquarters
Princeton, New Jersey, United States of America
Fiscal year end
12-31
Website
urogen.com

Company profile

Exchange
US
Symbol
URGN
Market-cap rank
#2773
Listing date
2017-05-04
Market cap
1.36B
Float cap
1.20B
Shares out
49.05M
Float shares
43.57M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

UroGen Pharma Ltd discussion 0 comments

Add a comment